Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janine Mühe

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Virology|June 19, 2015
Host Range Restriction of Epstein-Barr Virus and Related LymphocryptovirusesJanine Mühe, Fred Wang
Current Topics in Microbiology and Immunology|October 3, 2015
Non-human Primate Lymphocryptoviruses: Past, Present, and FutureJanine Mühe, Fred Wang
Plos Pathogens|December 21, 2017
Species-specific functions of Epstein-Barr virus nuclear antigen 2 (EBNA2) reveal dual roles for initiation and maintenance of B cell immortalizationJanine Mühe, Fred Wang
Journal of Virology|November 13, 2015
Epstein-Barr Virus gp350 Can Functionally Replace the Rhesus Lymphocryptovirus Major Membrane Glycoprotein and Does Not Restrict Infection of Rhesus MacaquesMarissa Herrman, Janine Mühe, Carol Quink, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 30, 2024
Sequence-Optimized mRNA Vaccines Against Infectious DiseaseSusanne Rauch, Johannes Lutz, Janine Mühe, et al.
Current Topics in Microbiology and Immunology|July 12, 2025
Non-human Primate Lymphocryptoviruses: Past, Present, and FutureGabriela M Escalante, Ivana G Reidel, Janine Mühe, et al.
Cell Reports. Medicine|August 2, 2021
Neutralizing antibodies against Epstein-Barr virus infection of B cells can protect from oral viral challenge in the rhesus macaque animal modelJanine Mühe, Pyone Pyone Aye, Carol Quink, et al.
NPJ Vaccines|March 4, 2023
Immunogenicity and protective activity of mRNA vaccine candidates against yellow fever virus in animal modelsLex G Medina-Magües, Janine Mühe, Edith Jasny, et al.
Nature Communications|July 1, 2021
CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2Donata Hoffmann, Björn Corleis, Susanne Rauch, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Virology|June 19, 2015
Host Range Restriction of Epstein-Barr Virus and Related LymphocryptovirusesJanine Mühe, Fred Wang
Current Topics in Microbiology and Immunology|October 3, 2015
Non-human Primate Lymphocryptoviruses: Past, Present, and FutureJanine Mühe, Fred Wang
Plos Pathogens|December 21, 2017
Species-specific functions of Epstein-Barr virus nuclear antigen 2 (EBNA2) reveal dual roles for initiation and maintenance of B cell immortalizationJanine Mühe, Fred Wang
Journal of Virology|November 13, 2015
Epstein-Barr Virus gp350 Can Functionally Replace the Rhesus Lymphocryptovirus Major Membrane Glycoprotein and Does Not Restrict Infection of Rhesus MacaquesMarissa Herrman, Janine Mühe, Carol Quink, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 30, 2024
Sequence-Optimized mRNA Vaccines Against Infectious DiseaseSusanne Rauch, Johannes Lutz, Janine Mühe, et al.
Current Topics in Microbiology and Immunology|July 12, 2025
Non-human Primate Lymphocryptoviruses: Past, Present, and FutureGabriela M Escalante, Ivana G Reidel, Janine Mühe, et al.
Cell Reports. Medicine|August 2, 2021
Neutralizing antibodies against Epstein-Barr virus infection of B cells can protect from oral viral challenge in the rhesus macaque animal modelJanine Mühe, Pyone Pyone Aye, Carol Quink, et al.
NPJ Vaccines|March 4, 2023
Immunogenicity and protective activity of mRNA vaccine candidates against yellow fever virus in animal modelsLex G Medina-Magües, Janine Mühe, Edith Jasny, et al.
Nature Communications|July 1, 2021
CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2Donata Hoffmann, Björn Corleis, Susanne Rauch, et al.
Pageof 1